# Kuling Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kuling-biology

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Angel (May 24, 2017)
- Investors on record: 1

## About

Established in 2014, and based in Beijng, China, Kuling Biology is a small molecule drug company that screens and identifies small-molecule drug and develops clinics. In May 2017, it closed an angel funding from Bohe Angel Fund.

Kuling Biology focuses on immune-related small-molecule drug screening, identification, and clinical development. 

The company generates revenue by developing small-molecule drug screening identification and clinics.

## Funding rounds

- Angel, May 24, 2017 — Bohe Angel Fund

## Investors

- Bohe Angel Fund — Angel